Viewing Study NCT05582694

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-05-08 @ 11:44 AM
Study NCT ID: NCT05582694
Status: WITHDRAWN
Last Update Posted: 2025-07-11
First Post: 2022-10-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Trial of Anti-CD4 Antibody UB-421 in Combination With Optimized Background Antiretroviral Therapy in Patients With Multi-Drug Resistant HIV-1 Infection
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multi-Drug Resistant Hiv-1 Infection View
None HIV-1 Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV Therapy View
None Cd4-Specific Humanized Igg1 Monoclonal Antibody View